Brevibloc (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the Brevibloc drug offered from Baxter Healthcare Corporation. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
| NON-PROPRIETARY NAME: | Esmolol Hydrochloride |
| SUBSTANCE NAME: | ESMOLOL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1986-12-31 |
| END MARKETING DATE: | 0000-00-00 |
Brevibloc HUMAN PRESCRIPTION DRUG Details:
| Item Description | Brevibloc from Baxter Healthcare Corporation |
| LABELER NAME: | Baxter Healthcare Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/mL) |
| START MARKETING DATE: | 1986-12-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 10019-055_b12ea3fc-85e7-4ab6-a8db-54f5ebaebd6e |
| PRODUCT NDC: | 10019-055 |
| APPLICATION NUMBER: | NDA019386 |
Other ESMOLOL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
